| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.007 |